% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@MISC{Hampton:282918,
      author       = {Hampton Leonard and Mike Nalls and Dan Vitale and Mathew
                      Koretsky and Kristin Levine and Mary Makarious and Fang,
                      Zih-Hua and Jones, Lietsel and Solle, J.},
      title        = {{D}ataset: {G}lobal {P}arkinson's {G}enetics {P}rogram
                      {D}ata {R}elease 11, v6},
      publisher    = {Zenodo},
      reportid     = {DZNE-2025-01379},
      year         = {2025},
      abstract     = {In December 2025, GP2 announced the 11th data release on
                      the Terra and the Verily® Workbench platforms in
                      collaboration with AMP® PD. This release includes 20,842
                      additional genotyped participants, 17,153 additional WGS
                      participants, and 4,232 additional clinical exomes. The
                      genotype array (NBA) data, including locally-restricted
                      samples, now consists of a total of 103,786 genotyped
                      participants (46,327 PD cases, 28,857 Controls, and 28,602
                      ‘Other’ phenotypes). The whole genome sequencing (WGS)
                      data now consists of a total of 38,226 sequenced
                      participants (18,219 PD cases, 9,172 Controls, and 10,835
                      ‘Other’ phenotypes). The clinical exome data now
                      consists of 14,648 samples with PD. Of the 122,317 unique
                      samples with genetic data (NBA, WGS, or clinical exome),
                      32,897 individuals also have additional extended clinical
                      information. Please see the accompanying blog for further
                      description of this release. To obtain data access, please
                      see https://amp-pd.org/researchers/data-use-agreement. For
                      any publications using data from this release, please
                      reference the DOI number and the following statement: 'Data
                      (DOI 10.5281/zenodo.17753486, release 11) and/or code used
                      in the preparation of this article were obtained from Global
                      Parkinson’s Genetics Program (GP2). GP2 is funded by the
                      Aligning Science Across Parkinson’s (ASAP) initiative and
                      implemented by The Michael J. Fox Foundation for
                      Parkinson’s Research (https://gp2.org). For a complete
                      list of GP2 members see https://gp2.org.'},
      cin          = {AG Heutink},
      cid          = {I:(DE-2719)1210002},
      pnm          = {354 - Disease Prevention and Healthy Aging (POF4-354)},
      pid          = {G:(DE-HGF)POF4-354},
      typ          = {PUB:(DE-HGF)32},
      doi          = {10.5281/ZENODO.17753486},
      url          = {https://pub.dzne.de/record/282918},
}